CA72-4 antigen levels in serum and peritoneal washing in gastric cancer. Correlation with morphological aspects of neoplasia

Arquivos de Gastroenterologia

Volumn 44, Issue 3, 2007, Pages 235-239

  Fernandes, Leonardo Landim ^a   Martins, Lourdes Conceição ^a   Nagashima, Carlos Alberto ^a   Nagae, Ana Cibele ^a   Waisberg, Daniel Reis ^a   Waisberg, Jaques ^a,b  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Adenocarcinoma; Gastric neoplasms; Peritoneal lavage; Tumor markers, biological

Indexed keywords

CA 72-4 ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURGERY; CELL DIFFERENTIATION; CLINICAL ARTICLE; DURA MATER; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MALE; PARTIAL GASTRECTOMY; PERITONEAL FLUID; PERITONEAL FLUID LEVEL; PREOPERATIVE PERIOD; SEROSA; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; VEIN PUNCTURE; VENOUS BLOOD;

EID: 36849046227     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032007000300011     Document Type: Article

References (37)

1. Abe N, Watanabe T, Toda H, Machida H, Suzuki K, Masaki T, Mori T, Sugiyama M, Atomi Y, Nakaya Y. Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer. Am J Surg. 2001;181:356-61.
2. Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg 1997;84:1651-64.
3. Asao T, Fukuda T, Yazawa S, Nagamachi Y. Carcinoembryonic antigen levels in peritoneal washings can predict peritoneal recurrence after resection of gastric cancer. Cancer. 1991;68:44-7.
4. Barbuto JAM, Oda EE, Oliveira RM. Análise em pacientes do hospital A. C. Camargo de dois marcadores tumorais: CA-72.4 e Cyfra-21.1. Acta Oncol Bras. 1995;15:89-93.
5. Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA19-9 and CA72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002;22:2311-6.
6. Colcher D, Keenan AM, Larson SM, Schlom J. Prolonged binding of a radio-labeled monoclonal antibody (B72-3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res. 1984;44(12 Pt 1):5744-51.
7. Fernández-Fernández L, Tejero E, Tieso A. Significance of CA72-4 in colorectal carcinoma. Comparison with CEA and CA19-9. Eur J Surg Oncol. 1995;21:388-90.
8. Fernández-Fernández L, Tejero E, Tieso A, Rabadán L, Muñoz M, Santos I. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA19-9 and CA72-4 in gastric cancer. Int Surg. 1996;81:400-2.
9. Filella X, Molina R, Bedini JL, Joseph J, Ballesta AM. Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease. Bull Cancer. 1992;79:271-7.
10. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med. 1986;104:66-73.
11. Guadagni F, Roselli M, Amato T, Cosimelli M, Mannella E, Perri P, Abbolito MR, Cavalieire R, Colche D, Greiner JW, Schlom J. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen (CEA) levels in monitoring patients with gastrointestinal carcinoma: a longitudinal study. Cancer. 1991;68:2443-50.
12. Guadagni F, Roselli M, Amato T, Cosimelli M, Perri P, Casale V, Carlini M, Santoro E, Cavaliere R, Greiner JW, Schlom J. CA72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res. 1992;52:1222-7.
13. Guadagni F, Roselli M, Cosimelli M, Mannella E, Tedesco M, Cavaliere F, Grassi A, Abbolito MR, Greiner JW, Schlom J. TAG 72-4 (CA72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer. 1993;72:2098-106.
14. Hamazoe R, Maeta M, Matsui T, Shibata S, Shiota S, Kaibara N. CA72-4 compared with carcinoembryonic antigen as a tumor marker for gastric cancer. Eur J Cancer. 1992;28A:1351-4.
15. Heptner G, Domschke S, Domschke W. Comparison of CA72-4 with CA19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol. 1989;24:745-50.
16. Ikeguchi M, Katano K, Saitou H, Tsujitani S, Maeta M, Kaibara N. Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma. Hepatogastroenterology. 1997;44:866-71.
17. Irinoda T, Terashima M, Takagane A, Sasaki N, Abe K, Araya M, Nishizuka S, Yonezawa H, Nakaya T, Shimooki O, Oyama K, Ikeda K, Saito K. Carcinoembryonic antigen level in peritoneal washing is a prognostic factor in patients with gastric cancer. Oncol Rep. 1998;5:661-6.
18. Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JI, Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. 1986;46:850-7.
19. Joypaul B, Browning M, Newman E, Byrne D, Cuschieri A. Comparison of serum CA72-4 and CA19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg. 1995;169:595-9.
20. Kodama I, Koufuji K, Kawabata S, Tetsu S, Tsuji Y, Takeda J, Kakegawa T. The clinical efficacy of CA72-4 as a serum marker for gastric cancer in comparison with CA19-9 and CEA. Int Surg. 1995;80:45-8.
21. Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA 19-9 and CA 125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology. 2002;49:1157-60.
22. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000;87:353-7.
23. Mandorwski S, Lourenço LG, Forones NM. CA72-4 CEA no soro e no lavado peritoneal de doentes com câncer gástrico. Arq Gastroenterol. 2002;39:17-21.
24. Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F. Clinical utility of CEA, CA19-9, and CA72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg. 2001;181:16-9.
25. Marrelli D, Pinto E, Stefano A, Manzoni G, Farnetani M, Garosi L, Roviello F. Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer. J Surg Oncol. 2001;78:253-8.
26. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, Pinto E. Prognostic significance of CEA, CA19-9 and CA72-4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57:55-62.
27. Mattar R, Alves de Andrade CR, DiFavero GM, Gama-Rodrigues JJ, Laudanna AA. Preoperative serum levels of CA72-4, CEA, CA19-9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med São Paulo. 2002;57:89-92.
28. Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukuma A, Enjoji M. Pathology and prognosis of gastric carcinoma: findings in 10.000 patients who underwent primary gastrectomy. Cancer. 1992;70:1030-7.
29. Nishiyama M, Takashima I, Tanaka T, Yoshida K, Toge T, Nagata N, Iwamori S, Tamura Y. Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg. 1995;19:133-7.
30. Ohuchi N, Simpson JF, Colcher D, Schlom J. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas. Int J Cancer. 1987;40:726-33.
31. Souza Jr OG, Souza EMN, Feio FMS. Correlação da dosagem sérica do CA19-9 em pacientes com adenocarcinoma gástrico. Rev Para Méd. 1999;13:29-33.
32. Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 1986;46:3118-24.
33. Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Cianetti A, Vannini P. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19-9 and CA72-4 in patients with gastric cancer. J Cancer Res Clin Oncol. 1998;124:450-5.
34. Tomasich FDS, Augusto VC, Luz MA, Dias LAN, Kato M. Correlaç ão entre os marcadores tumorais CEA e CA72-4 e a profundidade de invasão no câncer gástrico. Rev Bras Cancerol. 2002;48:57-62.
35. Ueno H, Yoshida K, Hirai T, Kono F, Kambe M, Toge T. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction. Anticancer Res. 2003;23:1701-8.
36. Yasasever V, Sengun Z, Saydan N, Onat H, Dalay N. Serum values of CA72.4 in patients with gastrointestinal system tumors comparison with CEA and CA19-9. Eur J Gynaecol Oncol. 1992;13:403-8.
37. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236-42.